Intrinsic Value of S&P & Nasdaq Contact Us

Lineage Cell Therapeutics, Inc. LCTX NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lineage Cell Therapeutics, Inc. (LCTX) has 20 known insider and institutional holders on record. The largest holder is BROADWOOD PARTNERS LP with 24,897,032 shares. Other notable holders include BROADWOOD PARTNERS, L.P. and KARFUNKEL GEORGE.

Over the last 12 months, insiders have made 14 transactions in LCTX stock — 10 buys (valued at $10M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

LCTX Insider Ownership

Top Holder
BROADWOOD PARTNERS LP
24,897,032 shares
Buys (12 mo)
10
$10M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 71%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Broadwood Partners Lp 10 Percent Owner 24,897,032 2016-06-23
100%
2 Broadwood Partners, L.p. 10 Percent Owner 7,894,737 2025-01-28
32%
3 Karfunkel George 10 Percent Owner 2,215,000 2009-08-24
9%
4 Duberstein Gary K 10 Percent Owner 2,097,985 2009-08-25
8%
5 Greenbelt Corp /ny Other: See Remarks 1,143,346 2017-01-06
5%
6 Howe Jill Ann Chief Financial Officer 1,050,000 2026-03-06
4%
7 Samuel George A. Iii General Counsel and Secretary 900,000 2026-03-06
4%
8 Leavitt Chase C. General Counsel/secretary 699,100 2021-03-17
3%
9 Cook Kevin Leon Chief Financial Officer 650,000 2022-03-11
3%
10 Roberts Brandi CFO & SVP Finance 616,700 2020-03-19
2%
11 Hogge Gary S. SVP,clinical & Medical Affairs 400,000 2023-03-10
2%
12 Greenway Partners L P 10 Percent Owner 375,351 2012-12-18
2%
13 Wirth Edward Chief Medical Officer 350,000 2019-03-21
1%
14 Culley Brian M President and CEO 255,516 2026-03-12
1%
15 Peabody Robert Sr. VP and CFO 100,000 2015-07-14
0%
16 Garcia Peter S Chief Financial Officer 100,000 2013-02-22
0%
17 Cartt Stephen Lahue Director 98,525 2015-08-18
0%
18 Nickel Jeffrey B Vice President 80,000 2006-11-28
0%
19 Mulroy Michael H. Director 75,000 2025-07-02
0%
20 Bradsher Neal C 10 Percent Owner 75,000 2025-07-03
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-12 Culley Brian M President and CEO Informative Buy 15,000 $1.63 $24.38K
2026-03-05 Howe Jill Ann Chief Financial Officer RSU Award 1,050,000 $1.84 $1.93M
2026-03-05 Samuel George A. Iii General Counsel and Secretary RSU Award 900,000 $1.84 $1.66M
2026-03-05 Culley Brian M President and CEO RSU Award 3,250,000 $1.84 $5.98M
2026-02-11 Samuel George A. Iii General Counsel and Secretary Option Exercise (Sell) 6,075 - -
2026-02-11 Culley Brian M President and CEO Option Exercise (Sell) 31,250 - -
2025-12-19 Samuel George A. Iii General Counsel and Secretary Tax Withholding of RSU 65 $1.68 $109.20
2025-12-19 Culley Brian M President and CEO Tax Withholding of RSU 334 $1.68 $561.12
2025-07-01 Bradsher Neal C 10 Percent Owner RSU Award 75,000 $0.90 $67.33K
2025-07-01 Amin Dipti Director RSU Award 75,000 $0.90 $67.33K
2025-07-01 Jayasuriya Anula Director RSU Award 75,000 $0.90 $67.33K
2025-07-01 Russell Angus C. Director RSU Award 75,000 $0.90 $67.33K
2025-07-01 Mulroy Michael H. Director RSU Award 75,000 $0.90 $67.33K
2025-07-01 Andrews Deborah J Director RSU Award 75,000 $0.90 $67.33K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message